IP Library Granted Patent US 8,722,114
Granted Patent B2
US 8,722,114 · App. 13/623,112 · Granted May 13, 2014

Compositions and methods for increasing human growth hormone levels

Inventors: Amy L. Heaton (Salt Lake City, UT); Mitchell K. Friedlander (Salt Lake City, UT); Dennis Gay (Salt Lake City, UT)
Assignee: Quality IP Holdings, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,722,114
App. No.
13/623,112
Granted
May 13, 2014
Kind
B2
Abstract

Embodiments of the invention generally relate to methods and supplements for increasing human growth hormone (hGH) levels in healthy human beings.

Claims (44)

1. A method of increasing human growth hormone in a healthy human being, comprising:

orally administering an effective amount of a nutritional supplement composition in unit dosage form to the healthy human being, wherein the unit dosage consists of:

about 1 mmol L-arginine;

about 1 mmol Oxo-proline;

about 2 mmol L-lysine;

about 1.5 μmol N-acetyl L-cysteine;

about 2 μmol L-glutamine; and

about 125 μg Schizonepta (aerial parts) powder.

2. The method of claim 1 , wherein orally administering the nutritional supplement composition to a healthy human being comprises orally administering the nutritional supplement composition to a human in an amount of 2.9 grams.

3. The method of claim 1 , wherein orally administering the nutritional supplement composition to a healthy human being comprises orally administering the nutritional supplement composition to a human in powder, tablet, capsule, liquid, or wafer form.

4. The method of claim 1 , wherein orally administering the nutritional supplement composition to a healthy human being comprises orally administering the nutritional supplement composition to a human from one to three times daily.

5. The method of claim 1 , wherein orally administering the nutritional supplement composition to a healthy human being comprises orally administering the nutritional supplement composition to a human once a week.

6. The method of claim 1 , wherein orally administering the nutritional supplement composition to a healthy human being comprises orally administering the nutritional supplement composition to a human on an empty stomach.

7. The method of claim 1 , wherein orally administering the nutritional supplement composition to a healthy human being comprises orally administering the nutritional supplement composition to a human that is at least 30 years old.

8. The method of claim 1 , wherein the unit dosage form consists of:

1.32 mmol Oxo-proline;

2.05 mmol L-lysine;

1.53 μmol N-acetyl L-cysteine;

1.71 μmol L-glutamine; and

125 μg Schizonepta (aerial parts) powder.

9. The method of claim 1 , wherein the unit dosage form consists of:

181.38 mg L-arginine HC1;

170.93 mg L-pyroglutamic acid;

374.83 mg L-lysine HCI;

0.25 mg N-acetyl L-cysteine USP;

0.25 mg L-glutamine; and

0.125 mg Schizonepta (aerial parts) powder.

10. The nutritional supplement composition of claim 1 , wherein the nutritional supplement unit dosage form is in capsule form.

11. A method of increasing human growth hormone in a healthy human being, comprising:

orally administering an effective amount of a serving of the nutritional supplement composition in unit dosage form to the healthy human being, wherein the unit dosage form consists of:

3.44 mmol L-arginine;

5.30 mmol Oxo-proline;

8.21 mmol L-lysine;

6.13 μmol N-acetyl L-cysteine;

6.84 μmol L-glutamine; and

0.50 mg Schizonepta (aerial parts) powder; and

orally administering the nutritional supplement composition to a healthy human being.

12. The method of claim 11 , wherein the unit dosage form consists of 725.50 mg L-arginine HCl; 683.70 mg L-pyroglutamic acid; 1499.30 mg L-lysine HCl; 1.00 mg N-acetyl L-cysteine USP; 1.00 mg L-glutamine; and 0.50 mg Schizonepta (aerial parts) powder.

13. The method of claim 11 , wherein orally administering the nutritional supplement composition to a healthy human being comprises orally administering the nutritional supplement composition to the healthy human being in an amount of 2.9 grams.

14. The method of claim 11 , wherein orally administering the nutritional supplement composition to a healthy human being comprises orally administering the nutritional supplement composition to the healthy human being in powder, tablet, capsule, liquid, or wafer form.

15. The method of claim 11 , wherein orally administering the nutritional supplement composition to a healthy human being comprises orally administering the nutritional supplement composition to the healthy human being from one to three times daily.

16. The method of claim 11 , wherein orally administering the nutritional supplement composition to a healthy human being comprises orally administering the nutritional supplement composition to the healthy human being once a week.

17. The method of claim 11 , wherein orally administering the nutritional supplement composition to a healthy human being comprises orally administering the nutritional supplement composition to the healthy human being on an empty stomach.

18. The method of claim 11 , wherein the healthy human being is a human that is at least 30 years old.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Jan 5, 2023
From: CASPAR CAPITAL LP
To: QUALITY IP HOLDINGS LLC
Reel/Frame 062283/0073 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2022
From: CERBERUS BUSINESS FINANCE, LLC
To: CASPAR CAPITAL LP
Reel/Frame 061636/0625 →
ASSIGNMENT OF SECURITY INTEREST Recorded Dec 30, 2019
From: LS2, LLC
To: CERBERUS BUSINESS FINANCE, LLC
Reel/Frame 051447/0114 →
SECURITY INTEREST Recorded Aug 21, 2015
From: QUALITY IP HOLDINGS, LLC
To: LS2, LLC
Reel/Frame 036392/0053 →
ASSIGNMENT FOR SECURITY - PATENTS Recorded Dec 4, 2014
From: QUALITY IP HOLDINGS, LLC
To: CERBERUS BUSINESS FINANCE, LLC, AS COLLATERAL AGENT
Reel/Frame 034535/0294 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 27, 2013
From: HEATON, AMY L; FRIEDLANDER, MITCHELL K; GAY, DENNIS
To: QUALITY IP HOLDINGS, LLC
Reel/Frame 031688/0754 →
Continuity (1)
Related Publication 20140079826A1 · Mar 20, 2014